These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23506378)

  • 1. Modulation of P2 receptors on pancreatic β-cells by agonists and antagonists: a molecular target for type 2 diabetes treatment.
    Pacheco PA; Ferreira LG; Alves LA; Faria RX
    Curr Diabetes Rev; 2013 May; 9(3):228-36. PubMed ID: 23506378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of P2X receptors in the regulation of insulin secretion, proliferation and survival in mouse pancreatic β-cells.
    Ohtani M; Ohura K; Oka T
    Cell Physiol Biochem; 2011; 28(2):355-66. PubMed ID: 21865744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages.
    Marques-da-Silva C; Burnstock G; Ojcius DM; Coutinho-Silva R
    Immunobiology; 2011; 216(1-2):1-11. PubMed ID: 20471713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2-type purinergic signaling in the regulation of pancreatic β-cell functional plasticity as a promising novel therapeutic approach for the treatment of type 2 diabetes?
    Mesto N; Movassat J; Tourrel-Cuzin C
    Front Endocrinol (Lausanne); 2022; 13():1099152. PubMed ID: 37065173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X and P2Y receptors—role in the pathophysiology of the nervous system.
    Puchałowicz K; Tarnowski M; Baranowska-Bosiacka I; Chlubek D; Dziedziejko V
    Int J Mol Sci; 2014 Dec; 15(12):23672-704. PubMed ID: 25530618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommended tool compounds and drugs for blocking P2X and P2Y receptors.
    Müller CE; Namasivayam V
    Purinergic Signal; 2021 Dec; 17(4):633-648. PubMed ID: 34476721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes.
    Yoshida S; Tanaka H; Oshima H; Yamazaki T; Yonetoku Y; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Oct; 400(4):745-51. PubMed ID: 20816753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of distinct P2Y receptor subtypes stimulates insulin secretion in MIN6 mouse pancreatic beta cells.
    Balasubramanian R; Ruiz de Azua I; Wess J; Jacobson KA
    Biochem Pharmacol; 2010 May; 79(9):1317-26. PubMed ID: 20067775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological and immunocytochemical evidence for P2X purinergic receptors in pancreatic beta cells.
    Silva AM; Rodrigues RJ; Tomé AR; Cunha RA; Misler S; Rosário LM; Santos RM
    Pancreas; 2008 Apr; 36(3):279-83. PubMed ID: 18362842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats.
    Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA
    J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X and P2Y nucleotide receptors as targets in cardiovascular disease.
    Kennedy C; Chootip K; Mitchell C; Syed NI; Tengah A
    Future Med Chem; 2013 Mar; 5(4):431-49. PubMed ID: 23495690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype.
    Santini E; Cuccato S; Madec S; Chimenti D; Ferrannini E; Solini A
    Endocrinology; 2009 Jun; 150(6):2596-602. PubMed ID: 19196799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural compounds acting at P2 receptors alleviate peripheral neuropathy.
    Zou L; Gong Y; Liu S; Liang S
    Brain Res Bull; 2019 Sep; 151():125-131. PubMed ID: 30599217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: a molecular and binding characterization.
    Lugo-Garcia L; Filhol R; Lajoix AD; Gross R; Petit P; Vignon J
    Eur J Pharmacol; 2007 Jul; 568(1-3):54-60. PubMed ID: 17509560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jia-Wei-Jiao-Tai-Wan ameliorates type 2 diabetes by improving β cell function and reducing insulin resistance in diabetic rats.
    Chen G; Yang X; Yang X; Li L; Luo J; Dong H; Xu L; Yi P; Wang K; Zou X; Lu F
    BMC Complement Altern Med; 2017 Nov; 17(1):507. PubMed ID: 29187178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants.
    Holst JJ; McGill MA
    Clin Drug Investig; 2012 Jan; 32(1):1-14. PubMed ID: 27933595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMP-activated protein kinase as regulator of P2Y(6) receptor-induced insulin secretion in mouse pancreatic β-cells.
    Balasubramanian R; Maruoka H; Jayasekara PS; Gao ZG; Jacobson KA
    Biochem Pharmacol; 2013 Apr; 85(7):991-8. PubMed ID: 23333427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2 purinergic signalling in the pancreatic beta-cell: control of insulin secretion and pharmacology.
    Petit P; Lajoix AD; Gross R
    Eur J Pharm Sci; 2009 May; 37(2):67-75. PubMed ID: 19429412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cells.
    Moran BM; Abdel-Wahab YH; Flatt PR; McKillop AM
    Diabetes Obes Metab; 2014 Nov; 16(11):1128-39. PubMed ID: 24919766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.